Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Olanzapine and Ziprasidone on Gene Expression in Healthy Subjects
NCT01185743Phase 4Completed
- Sponsor
- Medical University of Vienna
- Start
- Jul 2010
- Primary completion
- Jan 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of olanzapine and ziprasidone in schizophrenia, sponsored by Medical University of Vienna. Started Jul 2010; status: completed.
02
Drugs
olanzapineziprasidone
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT01185743.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01185743.